EIF2A and lung cancer: Finally, we revealed that EC therapy activates the PERK/eIF2α/ATF4 signaling pathway and promotes ER stress, thereby inducing ferroptosis in lung cancer cells and inhibiting the occurrence and development of lung cancer.